0 items USD 0.00Search
- Did you mean
- vancomycin
Your search for "Daptomycin" gave back 29 results.
Highlights The global Drugs for Vancomycin-Resistant Enterococcus Faecium market was valued at US$ million in 2022 and is anticipated to reach US$...
颁补迟补濒辞驳:听
MRRPB5
March 2023
Price: USD 2,900.00
The global market for VRE and MRSA Antibiotic was valued at US$ 4384 million in the year 2024 and is projected to reach a revised size of US$ 5747...
颁补迟补濒辞驳:听
MRRPB5
April 2025
Price: USD 2,900.00
Methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE) are specific, antibiotic-resistant bacteria that spread...
颁补迟补濒辞驳:听
MRRPB5
February 2024
Price: USD 2,900.00
The global VRE and MRSA Antibiotic market size was valued at US$ 3967.4 million in 2023. With growing demand in downstream market, the VRE and MRSA...
颁补迟补濒辞驳:听
LPI
January 2024
Price: USD 3,660.00
Methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE) are specific, antibiotic-resistant bacteria that spread...
颁补迟补濒辞驳:听
MRRPB5
January 2023
Price: USD 2,900.00
The global VRE and MRSA Antibiotic market size was valued at US$ 4511 million in 2024 and is forecast to a readjusted size of USD 5881 million by...
颁补迟补濒辞驳:听
GIR
July 2025
Price: USD 3,480.00
Methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE) are specific, antibiotic-resistant bacteria that spread...
颁补迟补濒辞驳:听
GIR
September 2024
Price: USD 3,480.00
Avecho Biotechnology Ltd - Strategy, SWOT and Corporate Finance Report Summary Avecho Biotechnology Ltd - Strategy, SWOT and Corporate Finance Report...
颁补迟补濒辞驳:听
MarketLine
October 2022
Price: USD 175.00
Vancomycin is an effective and safe antibiotic in the treatment of severe infections caused by methicillin-resistant staphylococcus aureus,...
颁补迟补濒辞驳:听
MRRPB5
June 2024
Price: USD 2,900.00
Vancomycin is an effective and safe antibiotic in the treatment of severe infections caused by methicillin-resistant staphylococcus aureus,...
颁补迟补濒辞驳:听
MRRPB5
May 2023
Price: USD 2,900.00
The global market for Methicillin-Resistant Staphylococcus Aureus (MRSA) Treatment was valued at US$ 3815 million in the year 2023 and is projected...
颁补迟补濒辞驳:听
MRRPB5
December 2024
Price: USD 2,900.00
Methicillin-resistant Staphylococcus aureus (MRSA) is a common bacterial infection pathogen that is more difficult to treat due to its resistance to...
颁补迟补濒辞驳:听
MRRPB5
April 2023
Price: USD 2,900.00
Methicillin-resistant Staphylococcus aureus (MRSA) is a common bacterial infection pathogen that is more difficult to treat due to its resistance to...
颁补迟补濒辞驳:听
MRRPB5
July 2024
Price: USD 2,900.00
Methicillin-resistant Staphylococcus aureus (MRSA) is a common bacterial infection pathogen that is more difficult to treat due to its resistance to...
颁补迟补濒辞驳:听
MRRPB5
October 2024
Price: USD 3,950.00
听
